Venous Thromboembolism Flashcards

1
Q

What two conditions are encompassed by venous thromboembolism?

A

Deep vein thrombosis (DVT)
Pulmonary embolism (PE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are signs and symptoms of a DVT?

A

Swelling and pain in the affected extremity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are signs and symptoms of PE?

A

Shortness of breath
Pleuritic chest pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

If PE or DVT is suspected, what’s a helpful test we can perform?

A

D-dimer

VTE can be excluded without imaging if patient has pre-test probabilities of low, moderate or unlikely in combo with negative d-dimer test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

If patient is diagnosed with distal DVT (calf veins) and symptoms are not severe, how do we manage?

A

No treatment needed.

Repeat imaging at 1 week
- No change, no treatment
- Significant clot extension, treat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When should we screen for thrombophilia? What is thrombophilia?

A

Patient age <40 year with recurrent VTE or family history

Blood that clots more easily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which VTE patients can be treated outpatient?

A

Majority of DVT patients
PE patients without compromised cardiopulmonary function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What’s the ideal analgesic for patients with VTE?

A

Acetaminophen
Opioids may be required for a few days

NSAIDs are effective but increases risk of bleeding, especially if using with anticoagulants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are non-pharms for DVT?

A

Rest if needed(reduces pain and swelling)

Evidence suggests early ambulation is preferred (resolves pain and swelling faster)

Elevate swollen limb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are non-pharms for PE?

A

Oxygen if hypoxic
IV fluids if hypotensive
Vasopressor if hypotensive or organ hypoperfusion (shock)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is a frequent complication of DVT?

A

Post-thrombotic syndrome (PTS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are signs and symptoms of PTS?

A

Chronic swelling and pain
Discomfort when walking
Skin discolouration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Does the compression stockings prevent development of PTS following DVT?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What can graduated compression stockings help with in DVT?

A

Improve edema and pain for DVT.
Relieve symptoms in those who do develop PTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What patient population should not use graduated compression stockings?

A

Patients with pre-existing peripheral vascular disease (PAD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the difference between PAD and DVT?

A

PAD= narrowed arteries in the legs
DVT= blood clot in the legs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the drug classes used in the treatment of VTE?

A
  • Direct oral anticoagulants (DOACs)
  • Warfarin
  • Low molecular weight heparin (LMWH)
  • Fondaparinux
  • Unfractionated heparin (UFH)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are drugs under the DOAC class?

A

Apixaban
Rivaroxaban
Dabigatran
Edoxaban

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the two types of DOACs?

A

Direct thrombin inhibitor
Direct Xa inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What DOACs are in which class?

A

Direct thrombin inhibitor
- Dabigatran

Direct Xa inhibitor
- Edoxaban
- Rivaroxaban
- Apixaban

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What makes apixaban and rivaroxaban different from dabigatran and edoxaban?

A

Dabigatran and edoxaban can only be used following a 5-10 days of parenteral anticoagulant

Apixaban and rivaroxaban can be used alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

If warfarin is used, do you need parenteral anticoagulation?

A

Yes, use together for a minimum of 5 days or until INR ≥2 for 24–48 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

When is parenteral anticoagulation preferred over oral?

A

Patients with significant comorbidities that need to be stabilized

When oral agents are contraindicated or ineffective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

When parenteral anticoagulation is selected, what are the three options?
Is there a preference out of the three?

A

LMWH
Fondaparinux
UFH

LMWH is recommended

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the recommended duration of oral anticoagulation for the treatment of DVT/PE?

A

If patient’s first episode and transient risk factors= 3 months
Unprovoked VTE or irreversible risk factors= indefinite treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is the mechanism of action of direct oral anticoagulants (DOAC)?

A

Dabigatran= directly inhibit the active site of thrombin
Apixaban, edoxaban, rivaroxaban= directly inhibit factor Xa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Is inhibiting factor Xa better than inhibiting thrombin?

A

Inhibiting factor Xa is considered a more targeted approach than targeting thrombin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

DOACs have a ______ onset of action. Drug levels peak in __-__ hrs. They also have ______ half lives of __-__ hrs.

A

Rapid
3-4
short
7-14

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Do DOACs have a lot of drug interactions?

A

Very few and no significant food interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What’s the benefit of giving DOACs?

A

They can be given in fixed dose and no monitoring of anticoagulant effect is needed.
Non-inferior for prevention of recurrent VTE compared to LMWH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Do DOACs have to be renally adjusted?

A

Yes so may not be appropriate for renal insufficiency.

Avoid dabigatran, edoxaban, and rivaroxaban if CrCl<30 ml/min.

Avoid apixaban if CrCl<15 mL/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What’s the antidote for dabigatran?

A

Idarucizumab

33
Q

What’s the antidote for direct Xa inhibitors?

A

Andexanet alpha

34
Q

Does LMWH have to renally adjusted?

35
Q

Is UFH or LMWH more predictable?

A

LMWH is more predictable and is an effective initial treatment of DVT in outpatients

36
Q

If unfractionated heparin is used for treatment of VTE, what is the common route?

37
Q

What’s a relatively rare but serious complication of UFH?

A

Heparin-indued thrombocytopenia (HIT)

38
Q

How do we manage HIT?

A

Stop immediately. Use a non-heparin alternative.
Start non-vitamin K antagonist anticoagulation should be initiated.

39
Q

UFH (usually IV), and LMWH (usually SC), is available in SC injection form. When should SC route be avoided?

A

Anasarca (severe swelling all over body) and patients on vasopressors.

40
Q

Warfarin (vitamin K antagonist) therapy should be titrated to maintain INR at what levels?

41
Q

How often is INR measured when initiating warfarin therapy?

A

Every other day for the first week
Every 3 days for a week
1-2 times weekly
Every 2-4 weeks once stable.

42
Q

What is the drug interaction between warfarin and ASA or NSAIDs?

A

Does not affect INR control but may contribute to bleeding by causing gastric irritation (NSAIDs) and inhibiting platelet function (INR)

43
Q

What are some common OTC interactions with warfarin?

A

Ginkgo
Ginseng
St. John’s wort

44
Q

Is ASA used in the treatment of VTE?

A

Can be considered, but was the least effective agent in a network meta-analysis

45
Q

Are thrombolytics often used in patients with VTE?

A

No, less than 10% are potential candidates

46
Q

When do we avoid the use of thrombolytics?

A

Short life expectancy
Poor functional status
High risk of bleeding (Ex: intracranial hemorrhage)

47
Q

If using a thrombolytic, when are the best results obtained?

A

If symptoms have existed for <14 days

48
Q

Thrombolytics are rarely required for DVT, but when are they usually recommended?

A
  • Hypotensive and not a high risk of bleeding
  • Deteriorating clinically with low bleeding risk
  • Life or limb threating thrombosis without bleeding contraindication
49
Q

Recommendation for thrombosis prophylaxis is based on surgery type. What surgeries have strong recommendation for post-op prophylaxis?

A
  • Elective total hip replacement
  • Elective total knee replacement
  • Hip fracture surgery
  • High-risk general and abdominal surgery
50
Q

Besides surgical patients, what other types of patients may also be a candidate for thrombosis prophylaxis?

A

Acute infection
Heart failure
Respiratory failure
Cancer (strongly consider)
ICU admission
Central line
History of prior VTE

51
Q

What’s the typical duration of prophylaxis?

A

At least 10-14 days
in high risk situations such as hip-knee arthroplasty, may need to continue post-discharge

52
Q

VTE is more common in patients with COVID 19. True or false?

A

True when they are hospitalized

53
Q

What is a non-pharm prophylaxis choice? When is this used instead of pharmacological choices?

A

Graduated compression stocking or intermittent pneumatic compression devices.

Reserved for when risk of bleeding is high (Ex: neurosurgery)

54
Q

If anticoagulants have failed or are contraindicated, what can we use to prevent lung clots?

A

Inferior vena cava filters

55
Q

What pharmacological choices are approved for prevention of VTE?

A

LMWH
- Dalteparin
- Enoxaparin
- Nadroparin
- Tinzaparin

Unfractionated heparin

Warfarin (target to INR 2-3)

ASA (equal efficacy and safety)
if combined with an initial 5 days of LMWH or DOAC

DOAC (not edoxaban)
- Apixaban
- Dabigatran
- Rivaroxaban

56
Q

What role does fondaparinux play in VTE? What is it’s mechanism of action?

A

Fondaparinux is only used in prevention of VTE. More so indicated in high-risk orthopedic patients.

It’s an indirect factor Xa inhibitor

57
Q

Is there a preference for prophylaxis agents for cancer patients?

A

LMWH injections or apixaban

58
Q

How do we manage acute VTE in pregnancy? (agent of choice? alternative?)

A

LMWH is the anticoagulant of choice.
UFH when LMWH not available

Both do not cross the placental barrier

59
Q

Why is LMWH preferred over UFH?

A

LMWH does not induce as much bone loss and can be used daily

60
Q

What’s the treatment duration for acute VTE in pregnancy?

A

A minimum of 3 months (including at least 6 weeks postpartum)

61
Q

Which agents should be avoided in pregnancy?

A

Warfarin, DOACs

62
Q

If fondaparinux ok to use in pregnancy?

A

Only if all other agents cannot be used

63
Q

What agents can we use for secondary prevention following delivery or during breastfeeding?

A

Warfarin, UFH, LMWH for 6 weeks after delivery.

Avoid DOACS

64
Q

Summary: If patient has isolated distal DVT/subsegmental PE, how do we manage?

A

Clinical surveillance or 3 months of anticoagulant therapy

65
Q

If patient has transient risk factors, how long do we treat for?

A

3 months of anticoagulant therapy

66
Q

If patient has unprovoked VTE, how long do we treat for?

A

3-6 months of anticoagulant therapy

Women with low recurrence risk= stop
Women with high recurrence and high bleeding= stop
Women with high recurrence but low/moderate bleeding = indefinite

Men with high bleeding= stop
Men with low to moderate bleeding risk= indefinite

67
Q

If VTE is cancer associated, how long is treatment?

A

6 months or as long as cancer is active

68
Q

Which DOAC has a unique dose adjustment depending on age and weight?

A

Apixaban 5mg BID usually

Change to 2.5mg BID if patient has two of the following:
≥ 80 years
Weight ≤ 60 kg
Serum creatinine ≥ 133 mcmol/L

69
Q

What is the typica dosing for apixaban?

A

10mg BID for 7 days, then 5 mg BID for 3-6 months

70
Q

What is the dosing for edoxaban?

A

60 mg daily after treating with parenteral anticoagulant for 5-10 days

71
Q

What is the dosing for rivaroxaban?

A

15mg BID PO x 3 weeks, then 20 mg PO daily

72
Q

What is the dosing for dabigatran?

A

<80y: 150 mg BID

≥80y = 110 mg BID

Following a treatment of parenteral anticoagulant for 5-10 days

73
Q

What are the treatment of choice for HIT?

A

Argatroban (does not need to be renally adjusted but is IV infusion)
Danaparoid

Other alternatives include
Fondaparinux (DoC between the alternatives)
Rivaroxaban
Bivalirudin

74
Q

If patient has HIT and does not want to have an IV infusion, what is the best choice?

A

Fondaparinux

75
Q

If patient has HIT and is renally impaired, what is the best choice?

A

Argatroban (no renal adjustment needed)

76
Q

What is the minimum duration of therapy for HIT?

A

At least 4 weeks

77
Q

What is the antidote for unfractionated heparin?

A

Protamine sulfate

78
Q

When does rivaroxaban have to be taken with food?

A

≥15 mg/day

79
Q

Which of the DOACs has dyspepsia as a side effect?

A

Dabigatran